Sun Pharma to Acquire Checkpoint Therapeutics
Press Releases

Sun Pharma to Acquire Checkpoint Therapeutics

Will add UNLOXCYT™ (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for

avatar profile Olean Times Herald

Olean Times Herald


Local & Social